• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » BASi Appoints COO, Expands Business Development Efforts

BASi Appoints COO, Expands Business Development Efforts

March 11, 2009
CenterWatch Staff

West Lafayette, Ind.-based CRO BASi appointed Anthony Chilton, Ph.D., chief operating officer, scientific services. In this role, Chilton will oversee scientific services provided to BASi’s clients from its locations in North America and Europe.

Chilton has over 30 years of experience as a scientist and executive in leading life sciences companies in England, Canada and the United States. Most recently, Chilton led early development programs at Atherogenics in Alpharetta, Ga.

“Dr. Chilton is a superb addition to our long-term scientific staff and leadership team,” said BASi president and CEO Richard Shepperd in a company statement. “His extensive industry expertise will be an asset to our partnerships with the biotech and pharmaceutical industry.”

The CRO also hired Jack Polidoro, Ph.D., as business development representative for BASi’s Evansville, Ind., operation. He will focus on large and small pharmaceutical, biotech and medical device clients. Polidoro, a reproductive biologist by training, brings more than 25 years of experience from the preclinical CRO business development arena.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing